Literature DB >> 19564587

Ophthalmoplegia and ptosis: mitochondrial toxicity in patients receiving HIV therapy.

G Pfeffer1, H C F Côté, J S Montaner, C C Li, M Jitratkosol, M M Mezei.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19564587      PMCID： PMC2830882          DOI： 10.1212/WNL.0b013e3181aae814

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  7 in total

Review 1.  Mechanisms of HIV and nucleoside reverse transcriptase inhibitor injury to mitochondria.

Authors:  Graeme Moyle
Journal:  Antivir Ther       Date:  2005

2.  Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors.

Authors:  Nils Venhoff; Bernhard Setzer; Kerstina Melkaoui; Ulrich A Walker
Journal:  Antivir Ther       Date:  2007

3.  Changes in metabolic toxicity after switching from stavudine/didanosine to tenofovir/lamivudine--a Staccato trial substudy.

Authors:  Jintanat Ananworanich; Reto Nuesch; Hélène C F Côté; Stephen J Kerr; Andrew Hill; Thidarat Jupimai; Naphassanant Laopraynak; Sukontha Saenawat; Kiat Ruxrungtham; Bernard Hirschel
Journal:  J Antimicrob Chemother       Date:  2008-03-12       Impact factor: 5.790

4.  Mitochondrial myopathy caused by long-term zidovudine therapy.

Authors:  M C Dalakas; I Illa; G H Pezeshkpour; J P Laukaitis; B Cohen; J L Griffin
Journal:  N Engl J Med       Date:  1990-04-19       Impact factor: 91.245

5.  Chronic progressive external ophthalmoplegia.

Authors:  G Danta; R C Hilton; P G Lynch
Journal:  Brain       Date:  1975-09       Impact factor: 13.501

Review 6.  Mitochondrial cytopathies.

Authors:  Janet Schmiedel; Sandra Jackson; Jochen Schäfer; Heinz Reichmann
Journal:  J Neurol       Date:  2003-03       Impact factor: 4.849

7.  Replication-competent human mitochondrial DNA lacking the heavy-strand promoter region.

Authors:  C T Moraes; F Andreetta; E Bonilla; S Shanske; S DiMauro; E A Schon
Journal:  Mol Cell Biol       Date:  1991-03       Impact factor: 4.272
  7 in total
  11 in total

Review 1.  Drug-related myopathies of which the clinician should be aware.

Authors:  Ritu Valiyil; Lisa Christopher-Stine
Journal:  Curr Rheumatol Rep       Date:  2010-06       Impact factor: 4.592

Review 2.  Update on toxic myopathies.

Authors:  F L Mastaglia; M Needham
Journal:  Curr Neurol Neurosci Rep       Date:  2012-02       Impact factor: 5.081

Review 3.  Mitochondrial optic neuropathies - disease mechanisms and therapeutic strategies.

Authors:  Patrick Yu-Wai-Man; Philip G Griffiths; Patrick F Chinnery
Journal:  Prog Retin Eye Res       Date:  2010-11-26       Impact factor: 21.198

Review 4.  Multisystem Proteinopathy Due to VCP Mutations: A Review of Clinical Heterogeneity and Genetic Diagnosis.

Authors:  Gerald Pfeffer; Grace Lee; Carly S Pontifex; Roberto D Fanganiello; Allison Peck; Conrad C Weihl; Virginia Kimonis
Journal:  Genes (Basel)       Date:  2022-05-27       Impact factor: 4.141

Review 5.  A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease.

Authors:  Christopher M Bailey; Karen S Anderson
Journal:  Biochim Biophys Acta       Date:  2010-01-18

6.  External ophthalmoplegia in human immunodeficiency virus-infected patients receiving antiretroviral therapy.

Authors:  Stacy L Pineles; Joseph L Demer; Gary N Holland; Susan S Ransome; Laura Bonelli; Federico G Velez
Journal:  J AAPOS       Date:  2012-11-14       Impact factor: 1.220

Review 7.  Neurological and psychiatric adverse effects of antiretroviral drugs.

Authors:  Michael S Abers; Wayne X Shandera; Joseph S Kass
Journal:  CNS Drugs       Date:  2014-02       Impact factor: 5.749

Review 8.  Progressive External Ophthalmoplegia.

Authors:  Collin McClelland; Georgios Manousakis; Michael S Lee
Journal:  Curr Neurol Neurosci Rep       Date:  2016-06       Impact factor: 5.081

Review 9.  Diagnosis and treatment of mitochondrial myopathies.

Authors:  Gerald Pfeffer; Patrick F Chinnery
Journal:  Ann Med       Date:  2011-08-25       Impact factor: 4.709

10.  Mitochondrial Toxicogenomics for Antiretroviral Management: HIV Post-exposure Prophylaxis in Uninfected Patients.

Authors:  Maria Bañó; Constanza Morén; Sergio Barroso; Diana Luz Juárez; Mariona Guitart-Mampel; Ingrid González-Casacuberta; Judith Canto-Santos; Ester Lozano; Agathe León; Enric Pedrol; Òscar Miró; Ester Tobías; Josep Mallolas; Jhon F Rojas; Francesc Cardellach; Esteban Martínez; Gloria Garrabou
Journal:  Front Genet       Date:  2020-05-26       Impact factor: 4.599
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.